Herpes Simplex Virus Encephalitis clinical trials

Explore recruiting herpes simplex virus encephalitis clinical trials.

Also recruiting in Europe

Herpes Simplex Virus Encephalitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Dexamethasone in Herpes Simplex Virus Encephalitis Open label Randomized Controlled Trial with an Observer-blinded evaluation at 6 months

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of intravenous single ascending doses of IM-250 in healthy volunteers.

Bulgaria

Human Pharmacology (Phase I)- Other EU CTIS Study details

Herpes Simplex Virus Encephalitis trials by city

Herpes Simplex Virus Encephalitis in Toronto Herpes Simplex Virus Encephalitis in Vancouver Herpes Simplex Virus Encephalitis in Montreal Herpes Simplex Virus Encephalitis in Calgary Herpes Simplex Virus Encephalitis in Edmonton Herpes Simplex Virus Encephalitis in Ottawa Herpes Simplex Virus Encephalitis in Winnipeg Herpes Simplex Virus Encephalitis in Quebec City Herpes Simplex Virus Encephalitis in Hamilton Herpes Simplex Virus Encephalitis in Kitchener Herpes Simplex Virus Encephalitis in London Herpes Simplex Virus Encephalitis in Halifax Herpes Simplex Virus Encephalitis in New York Herpes Simplex Virus Encephalitis in Los Angeles Herpes Simplex Virus Encephalitis in Chicago Herpes Simplex Virus Encephalitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease